Haemonetics (HAE) Misses Q4 EPS by 5c; Guides FY16 EPS
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $108.40 --0%
Revenue Growth %: +5.5%
Financial Fact:
Net income: 0.39
Today's EPS Names:
ALZN, ASPU, OCCI, More
Revenue Growth %: +5.5%
Financial Fact:
Net income: 0.39
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q4 EPS of $0.47, $0.05 worse than the analyst estimate of $0.52. Revenue for the quarter came in at $226.5 million versus the consensus estimate of $239.2 million.
Haemonetics sees FY2015 EPS of $1.98-$2.08, versus the consensus of $2.09.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi upgrades Haemonetics to Buy, raises price target to $123
- Haemonetics (HAE) spreader of 500 contracts of November 115 and 130 calls as share price up 2.5%
- Investing.com’s stocks of the week
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
